{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:33:36Z","timestamp":1784046816627,"version":"3.55.0"},"reference-count":26,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is currently one of the most common hepatic disorders observed in daily medical practice [...]<\/jats:p>","DOI":"10.3390\/life15030363","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T12:01:17Z","timestamp":1740484877000},"page":"363","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Non-Alcoholic Fatty Liver Disease in Everyday Clinical Practice: From Diagnosis to Therapy"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0609-9657","authenticated-orcid":false,"given":"Marcin","family":"Kosmalski","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology, Medical University of Lodz, 90-153 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1331-8408","authenticated-orcid":false,"given":"\u0141ukasz","family":"Mokros","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, Medical University of Lodz, 92-213 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"NAFLD Consensus Consortium. Advancing the global public health agenda for NAFLD: A consensus statement","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"103043","DOI":"10.1016\/j.arcmed.2024.103043","article-title":"Global Prevalence of Nonalcoholic Fatty Liver Disease: An Updated Review Meta-Analysis comprising a Population of 78 million from 38 Countries","volume":"55","author":"Letafatkar","year":"2024","journal-title":"Arch. Med. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.3350\/cmh.2022.0424","article-title":"Non-alcoholic fatty liver disease: Definition and subtypes","volume":"29","author":"Han","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Kounatidis, D., Vallianou, N.G., Geladari, E., Panoilia, M.P., Daskou, A., Stratigou, T., Karampela, T., Tsilingiris, D., and Dalamaga, M. (2024). NAFLD in the 21st Century: Current Knowledge Regarding Its Pathogenesis, Diagnosis and Therapeutics. Biomedicines, 12.","DOI":"10.3390\/biomedicines12040826"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jceh.2022.11.006","article-title":"Hepatic, Extra-hepatic Outcomes and Causes of Mortality in NAFLD\u2014An Umbrella Overview of Systematic Review of Meta-Analysis","volume":"13","author":"Xiao","year":"2023","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"101133","DOI":"10.1016\/j.aohep.2023.101133","article-title":"NAFLD Nomenclature consensus group. A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"29","author":"Rinella","year":"2024","journal-title":"Ann. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.62347\/KMSA5983","article-title":"Non-alcoholic fatty liver disease: Pathogenesis and models","volume":"16","author":"Zhong","year":"2024","journal-title":"Am. J. Transl. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"92864","DOI":"10.4291\/wjgp.v15.i1.92864","article-title":"Changes in the terminology and diagnostic criteria of non-alcoholic fatty liver disease: Implications and opportunities","volume":"15","author":"Mubarak","year":"2024","journal-title":"World J. Gastrointest. Pathophysiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s13679-024-00574-z","article-title":"Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review from NAFLD to MAFLD and MASLD","volume":"13","author":"Abdelhameed","year":"2024","journal-title":"Curr. Obes. Rep."},{"key":"ref_10","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), and European Association for the Study of Obesity (EASO) (2024). EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J. Hepatol., 81, 492\u2013542."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/17474124.2024.2435504","article-title":"MASLD: Predictive value for liver-related events and extra-hepatic complications","volume":"18","author":"Jamalinia","year":"2024","journal-title":"Expert. Rev. Gastroenterol. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Kosmalski, M., Frankowski, R., R\u00f3\u017cycka-Kosmalska, M., Sipowicz, K., Pietras, T., and Mokros, \u0141. (2023). The Association between Personality Factors and Metabolic Parameters among Patients with Non-Alcoholic-Fatty Liver Disease and Type 2 Diabetes Mellitus-A Cross-Sectional Study. J. Clin. Med., 12.","DOI":"10.3390\/jcm12134468"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Pezzino, S., Luca, T., Castorina, M., Puleo, S., Latteri, S., and Castorina, S. (2024). Role of Perturbated Hemostasis in MASLD and Its Correlation with Adipokines. Life, 14.","DOI":"10.3390\/life14010093"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Ferenc, K., Jarmakiewicz-Czaja, S., and Filip, R. (2023). What Does Sarcopenia Have to Do with Nonalcoholic Fatty Liver Disease?. Life, 14.","DOI":"10.3390\/life14010037"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Elshaer, A., Chascsa, D.M.H., and Lizaola-Mayo, B.C. (2024). Exploring Varied Treatment Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Life, 14.","DOI":"10.3390\/life14070844"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Boccatonda, A., Del Cane, L., Marola, L., D\u2019Ardes, D., Lessiani, G., di Gregorio, N., Ferri, C., Cipollone, F., Serra, C., and Santilli, F. (2024). Platelet, Antiplatelet Therapy and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review. Life, 14.","DOI":"10.3390\/life14040473"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Nagai, K., Nagai, K., Iwaki, M., Kobayashi, T., Nogami, A., Oka, M., Saito, S., and Yoneda, M. (2023). Frontiers of Collaboration between Primary Care and Specialists in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review. Life, 13.","DOI":"10.3390\/life13112144"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cmet.2023.01.006","article-title":"The role of hepatokines in NAFLD","volume":"35","author":"Stefan","year":"2023","journal-title":"Cell Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.clnu.2024.05.042","article-title":"Inflammatory markers as diagnostic and precision nutrition tools for metabolic dysfunction-associated steatotic liver disease: Results from the Fatty Liver in Obesity trial","volume":"43","author":"Milagro","year":"2024","journal-title":"Clin. Nutr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.3748\/wjg.v30.i47.5086","article-title":"Inflammatory biomarkers as cost-effective predictive tools in metabolic dysfunction-associated fatty liver disease","volume":"30","author":"Ramoni","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Abu-Freha, N., Cohen, B., Gordon, M., Weissmann, S., Fich, A., Munteanu, D., Yardeni, D., and Etzion, O. (2023). Comorbidities and Malignancy among NAFLD Patients Compared to the General Population, A Nation-Based Study. Biomedicines, 11.","DOI":"10.3390\/biomedicines11041110"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Portincasa, P., Khalil, M., Mahdi, L., Perniola, V., Idone, V., Graziani, A., Baffy, G., and Di Ciaula, A. (2024). Metabolic Dysfunction-Associated Steatotic Liver Disease: From Pathogenesis to Current Therapeutic Options. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25115640"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.14740\/gr1707","article-title":"Clinical Overview of Sarcopenia, Frailty, and Malnutrition in Patients with Liver Cirrhosis","volume":"17","author":"Kusnik","year":"2024","journal-title":"Gastroenterol. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e078933","DOI":"10.1136\/bmjopen-2023-078933","article-title":"Association between non-alcoholic fatty liver disease and risk of sarcopenia: A systematic review and meta-analysis","volume":"14","author":"Deng","year":"2024","journal-title":"BMJ Open"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Stankevicius, C., Davis, R.H., Huynh, D., Hatzi, M., Morgillo, S., and Day, A.S. (J. Dig. Dis., 2025). Sarcopenia as a Risk Factor for Mortality in NAFLD: How Should We Diagnose It?, J. Dig. Dis., online ahead of print.","DOI":"10.1111\/1751-2980.13329"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejim.2024.01.005","article-title":"Dietary and pharmacological treatment in patients with metabolic-dysfunction associated steatotic liver disease","volume":"122","author":"Armandi","year":"2024","journal-title":"Eur. J. Intern. Med."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/3\/363\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:42:32Z","timestamp":1760028152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/3\/363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["life15030363"],"URL":"https:\/\/doi.org\/10.3390\/life15030363","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]}}}